Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Oncology Reports|March 24, 2018
Mucosal Melanoma: a Literature ReviewSimon Skovsted Yde, Pia Sjoegren, Martin Heje, et al.Annals of Surgical Oncology|March 15, 2008
Extensive pathological analysis of selected melanoma sentinel lymph nodes: high metastasis detection rates at reduced workloadRikke Riber-Hansen, Pia Sjoegren, Stephen Jacques Hamilton-Dutoit, et al.Histopathology|July 29, 2009
Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survivalRikke Riber-Hansen, Jens R Nyengaard, Stephen J Hamilton-Dutoit, et al.Histopathology|November 1, 2011
Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survivalRikke Riber-Hansen, Jens R Nyengaard, Stephen J Hamilton-Dutoit, et al.Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapyBettina Dencker Hansen, Henrik Schmidt, Hans von der Maase, et al.Cancer|September 29, 2011
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanomaTrine O Jensen, Henrik Schmidt, Holger J Møller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanomaTrine O Jensen, Henrik Schmidt, Holger Jon Møller, et al.The Journal of Investigative Dermatology|January 18, 2006
Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanomaHenrik Schmidt, Boe S Sorensen, Pia Sjoegren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2006
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanomaHenrik Schmidt, Julia S Johansen, Pia Sjoegren, et al.Pageof 1